230 related articles for article (PubMed ID: 28193829)
1. Soluble CD83 Inhibits T Cell Activation by Binding to the TLR4/MD-2 Complex on CD14
Horvatinovich JM; Grogan EW; Norris M; Steinkasserer A; Lemos H; Mellor AL; Tcherepanova IY; Nicolette CA; DeBenedette MA
J Immunol; 2017 Mar; 198(6):2286-2301. PubMed ID: 28193829
[TBL] [Abstract][Full Text] [Related]
2. Soluble CD83 inhibits acute rejection by up regulating TGF-β and IDO secretion in rat liver transplantation.
Xiong L; Wang D; Lin S; Wang Y; Luo M; Gao L
Transpl Immunol; 2021 Feb; 64():101351. PubMed ID: 33171217
[TBL] [Abstract][Full Text] [Related]
3. Eukaryotic expression of functionally active recombinant soluble CD83 from HEK 293T cells.
Staab C; Mühl-Zürbes P; Steinkasserer A; Kummer M
Immunobiology; 2010; 215(9-10):849-54. PubMed ID: 20576314
[TBL] [Abstract][Full Text] [Related]
4. Soluble CD83 Triggers Resolution of Arthritis and Sustained Inflammation Control in IDO Dependent Manner.
Royzman D; Andreev D; Stich L; Rauh M; Bäuerle T; Ellmann S; Boon L; Kindermann M; Peckert K; Bozec A; Schett G; Steinkasserer A; Zinser E
Front Immunol; 2019; 10():633. PubMed ID: 31001257
[TBL] [Abstract][Full Text] [Related]
5. Atractylenolide I modulates ovarian cancer cell-mediated immunosuppression by blocking MD-2/TLR4 complex-mediated MyD88/NF-κB signaling in vitro.
Liu H; Zhang G; Huang J; Ma S; Mi K; Cheng J; Zhu Y; Zha X; Huang W
J Transl Med; 2016 Apr; 14(1):104. PubMed ID: 27118139
[TBL] [Abstract][Full Text] [Related]
6. Soluble CD14 and CD83 from human neonatal antigen-presenting cells are inducible by commensal bacteria and suppress allergen-induced human neonatal Th2 differentiation.
Lundell AC; Andersson K; Josefsson E; Steinkasserer A; Rudin A
Infect Immun; 2007 Aug; 75(8):4097-104. PubMed ID: 17526743
[TBL] [Abstract][Full Text] [Related]
7. The expression and characterization of functionally active soluble CD83 by Pichia pastoris using high-density fermentation.
Guo Y; Li R; Song X; Zhong Y; Wang C; Jia H; Wu L; Wang D; Fang F; Ma J; Kang W; Sun J; Tian Z; Xiao W
PLoS One; 2014; 9(2):e89264. PubMed ID: 24586642
[TBL] [Abstract][Full Text] [Related]
8. Soluble CD83 suppresses experimental food allergy via regulating aberrant T helper 2 responses.
Song W; Li H; Jia B; Wang Z; Liu Q; Yang G; Li X
Immunol Res; 2020 Jun; 68(3):141-151. PubMed ID: 32529460
[TBL] [Abstract][Full Text] [Related]
9. Bovine lactoferrin counteracts Toll-like receptor mediated activation signals in antigen presenting cells.
Puddu P; Latorre D; Carollo M; Catizone A; Ricci G; Valenti P; Gessani S
PLoS One; 2011; 6(7):e22504. PubMed ID: 21799877
[TBL] [Abstract][Full Text] [Related]
10. The soluble CD83 protein prevents bone destruction by inhibiting the formation of osteoclasts and inducing resolution of inflammation in arthritis.
Royzman D; Andreev D; Stich L; Peckert-Maier K; Wild AB; Zinser E; Mühl-Zürbes P; Jones E; Adam S; Frey S; Fuchs M; Kunz M; Bäuerle T; Nagel L; Schett G; Bozec A; Steinkasserer A
Front Immunol; 2022; 13():936995. PubMed ID: 36003376
[TBL] [Abstract][Full Text] [Related]
11. Topical application of soluble CD83 induces IDO-mediated immune modulation, increases Foxp3+ T cells, and prolongs allogeneic corneal graft survival.
Bock F; Rössner S; Onderka J; Lechmann M; Pallotta MT; Fallarino F; Boon L; Nicolette C; DeBenedette MA; Tcherepanova IY; Grohmann U; Steinkasserer A; Cursiefen C; Zinser E
J Immunol; 2013 Aug; 191(4):1965-75. PubMed ID: 23851696
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte-macrophage colony-stimulating factor drives monocytes to CD14low CD83+ DCSIGN- interleukin-10-producing myeloid cells with differential effects on T-cell subsets.
Ganguly D; Paul K; Bagchi J; Rakshit S; Mandal L; Bandyopadhyay G; Bandyopadhyay S
Immunology; 2007 Aug; 121(4):499-507. PubMed ID: 17433076
[TBL] [Abstract][Full Text] [Related]
13. Lipopolysaccharide-binding protein-mediated Toll-like receptor 4 dimerization enables rapid signal transduction against lipopolysaccharide stimulation on membrane-associated CD14-expressing cells.
Tsukamoto H; Fukudome K; Takao S; Tsuneyoshi N; Kimoto M
Int Immunol; 2010 Apr; 22(4):271-80. PubMed ID: 20133493
[TBL] [Abstract][Full Text] [Related]
14. Soluble human CD83 ameliorates lupus in NZB/W F1 mice.
Starke C; Steinkasserer A; Voll RE; Zinser E
Immunobiology; 2013 Nov; 218(11):1411-5. PubMed ID: 23886695
[TBL] [Abstract][Full Text] [Related]
15. CD83-stimulated monocytes suppress T-cell immune responses through production of prostaglandin E2.
Chen L; Zhu Y; Zhang G; Gao C; Zhong W; Zhang X
Proc Natl Acad Sci U S A; 2011 Nov; 108(46):18778-83. PubMed ID: 22065790
[TBL] [Abstract][Full Text] [Related]
16. Altered biliary epithelial cell and monocyte responses to lipopolysaccharide as a TLR ligand in patients with primary biliary cirrhosis.
Zhao J; Zhao S; Zhou G; Liang L; Guo X; Mao P; Zhou X; Wang H; Nan Y; Xu D; Yu J
Scand J Gastroenterol; 2011 Apr; 46(4):485-94. PubMed ID: 21275501
[TBL] [Abstract][Full Text] [Related]
17. CD83 is locally regulated and differentially expressed in disturbed murine pregnancy.
Einenkel R; Packhäuser KRH; Ehrhardt J; Tüngler A; Zygmunt M; Muzzio DO
Reproduction; 2019 Oct; 158(4):323-333. PubMed ID: 31426030
[TBL] [Abstract][Full Text] [Related]
18. Production and characterization of human soluble CD83 fused with the fragment crystallizable region of human IgG1 in Pichia pastoris.
Yuan Y; Wan L; Chen Y; Shi M; Wang C; Zhao J; Lu X; Wang H; Lu Y; Cheng J
Appl Microbiol Biotechnol; 2013 Nov; 97(21):9409-17. PubMed ID: 23392767
[TBL] [Abstract][Full Text] [Related]
19. Soluble CD83 ameliorates experimental colitis in mice.
Eckhardt J; Kreiser S; Döbbeler M; Nicolette C; DeBenedette MA; Tcherepanova IY; Ostalecki C; Pommer AJ; Becker C; Günther C; Zinser E; Mak TW; Steinkasserer A; Lechmann M
Mucosal Immunol; 2014 Jul; 7(4):1006-18. PubMed ID: 24424524
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells.
Brossart P; Zobywalski A; Grünebach F; Behnke L; Stuhler G; Reichardt VL; Kanz L; Brugger W
Cancer Res; 2000 Aug; 60(16):4485-92. PubMed ID: 10969796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
